statistiche ricercatore

Continente	#
NA - Nord America	525
AS - Asia	452
EU - Europa	322
SA - Sud America	59
AF - Africa	20
Continente sconosciuto - Info sul continente non disponibili	20
OC - Oceania	1
Totale	1.399

Nazione	#
US - Stati Uniti d'America	503
SG - Singapore	191
RU - Federazione Russa	166
VN - Vietnam	99
CN - Cina	82
IT - Italia	50
BR - Brasile	47
HK - Hong Kong	29
NL - Olanda	28
DE - Germania	20
FR - Francia	13
CI - Costa d'Avorio	12
CA - Canada	11
GB - Regno Unito	11
FI - Finlandia	9
IE - Irlanda	9
JP - Giappone	8
IN - India	6
AR - Argentina	5
KR - Corea	5
BD - Bangladesh	4
LT - Lituania	4
TR - Turchia	4
IQ - Iraq	3
TH - Thailandia	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
CO - Colombia	2
EG - Egitto	2
GR - Grecia	2
GT - Guatemala	2
JO - Giordania	2
MX - Messico	2
NG - Nigeria	2
NI - Nicaragua	2
PH - Filippine	2
PL - Polonia	2
PY - Paraguay	2
SE - Svezia	2
UA - Ucraina	2
AM - Armenia	1
AT - Austria	1
AU - Australia	1
AW - Aruba	1
AZ - Azerbaigian	1
CH - Svizzera	1
CW - ???statistics.table.value.countryCode.CW???	1
EE - Estonia	1
ES - Italia	1
HT - Haiti	1
ID - Indonesia	1
IR - Iran	1
JM - Giamaica	1
KH - Cambogia	1
ML - Mali	1
NP - Nepal	1
PA - Panama	1
PK - Pakistan	1
PS - Palestinian Territory	1
SN - Senegal	1
SO - Somalia	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TJ - Tagikistan	1
TW - Taiwan	1
UZ - Uzbekistan	1
ZA - Sudafrica	1
Totale	1.380

Nome	#
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer	174
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance	164
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS)	155
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study	144
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer	144
The emerging role of obesity, diet and lipid metabolism in prostate cancer	139
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance	139
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy	130
Early and late complications of double pigtail ureteral stent	107
Impact of laparoscopy on the management of an unusual case of nonpalpable testis in an adult patient	103
Totale	1.399

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	60	0	0	0	0	0	1	0	0	8	6	19	26
2022/2023	100	11	3	6	1	10	10	0	10	17	23	8	1
2023/2024	73	1	5	19	6	7	8	0	13	2	0	5	7
2024/2025	315	7	4	0	5	13	14	34	19	20	31	144	24
2025/2026	655	74	30	63	72	121	29	109	30	59	37	20	11
2026/2027	105	14	31	14	46	0	0	0	0	0	0	0	0
Totale													1.399